ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för E3040. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

13 träffar

Bibliografisk träff 2004-12-14

Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumen.

Adachi Y, Suzuki H, Schinkel AH, Sugiyama Y.

Mol Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1124/mol.104.007393

Bibliografisk träff 2004-09-01

Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice.

Mizuno N, Suzuki M, Kusuhara H, Suzuki H, Takeuchi K, Niwa T, Jonker JW, Sugiyama Y.

Drug Metab Dispos · comparative study; journal article · DOI 10.1016/s0090-9556(24)02969-6

Bibliografisk träff 2002-06-01

E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon.

Sakai H, Suzuki T, Murota M, Oketani K, Uchiumi T, Murakami M, Takeguchi N.

Br J Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/sj.bjp.0704723

Bibliografisk träff 2001-09-01

Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide.

Oketani K, Inoue T, Murakami M.

Eur J Pharmacol · journal article · DOI 10.1016/s0014-2999(01)01234-1

Bibliografisk träff 2001-06-01

In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.

Oketani K, Nagakura N, Harada K, Inoue T.

Eur J Pharmacol · journal article · DOI 10.1016/s0014-2999(01)01022-6

Bibliografisk träff 2000-10-01

Effect of anti-inflammatory bowel disease drug, E3040, on urate transport in rat renal brush border membrane vesicles.

Yamada H, Kotaki H, Itoh T, Sawada Y, Iga T.

Eur J Pharmacol · journal article · DOI 10.1016/s0014-2999(00)00626-9

Bibliografisk träff 1999-07-01

Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: study using DBA/2N mice.

Yamada H, Kotaki H, Furitsu H, Sawada Y, Iga T.

Biopharm Drug Dispos · journal article · DOI 10.1002/(sici)1099-081x(199907)20:5<271::aid-bdd185>3.0.co;2-i

Bibliografisk träff 1999-03-01

Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemia.

Yamada H, Kotaki H, Furitsu H, Sawada Y, Iga T.

Biopharm Drug Dispos · journal article · DOI 10.1002/(sici)1099-081x(199903)20:2<77::aid-bdd154>3.0.co;2-d

Bibliografisk träff 1997-08-01

Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide.

Niinuma K, Takenaka O, Horie T, Kobayashi K, Kato Y, Suzuki H, Sugiyama Y.

J Pharmacol Exp Ther · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-3565(24)36868-5

Bibliografisk träff 1997-02-01

Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo.

Takenaka O, Horie T, Suzuki H, Sugiyama Y.

J Pharmacol Exp Ther · comparative study; journal article · DOI 10.1016/s0022-3565(24)36463-8

Bibliografisk träff 1995-11-01

Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.

Takenaka O, Horie T, Kobayashi K, Suzuki H, Sugiyama Y.

Pharm Res · journal article · DOI 10.1023/a:1016278008658

Bibliografisk träff 1995-10-01

Synthesis of a novel dual inhibitor of thromboxane A2 synthetase and 5-lipoxygenase (E3040) via the direct coupling reaction of hydroquinone with 3-pyridinecarboxaldehyde.

Komatsu Y, Minami N.

Chem Pharm Bull (Tokyo) · journal article · DOI 10.1248/cpb.43.1614

Bibliografisk träff 1995-09-01

Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.

Takenaka O, Horie T, Suzuki H, Sugiyama Y.

J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(25)10666-6